Solutions
eClinical
TrialMaster
CTMS Master
RTSM Master
AnjuEPS
Medical Affairs
IRMS MAX
iCare MAX
Pubstrat MAX
MA Knowledge
Data Science
TA Scan
Services
eClinical Services
Medical Affairs Services
Data Science Services
Technology
Resources
Insights
Press Releases
Events
Partner Program
Company
About Anju
Careers
Management
Contact Us
Contact Support
Request A Demo
Inquiries & Locations
Home
/
Archives for Lisa Pahl
/
Page 11
Author:
Lisa Pahl
Tags
Do No Harm: How to Mitigate Risk in Child and FIH Clinical Trials
Tech Skills and Digital Natives in Demand as Clinical Trial Industry Evolves
Insights from DIA 2019 Global Annual Meeting
How to Foster Positive Relationships with Patient Advocates — and Why It’s Important
More than Reduced Costs: The Benefits of Remote Monitoring in Clinical Trials
How Tech Can Streamline Communication Between Clinical Trial Sites, Sponsors and CROs
How to Simplify the Clinical Trial Regulatory Submission Process
Beyond Numbers: One Family’s Clinical Trial Journey (Part 1)
There is no other event like DIA 2019 Global Annual Meeting
Visit us at The PharmaSUG 2019: June 16-19 in Philadelphia
Price Check: How to Cut Costs in Clinical Trials
Patients as Partners: The Value of Post-Trial Communication
The 66th Yaku-Kon Seminar in Ghent, Belgium
Bias in Clinical Trial Incentives
The Ugly Truth About Paper Diaries
PUBSTRAT’s 2019 Resurgence: Innovation & Service-Driven
Expert Hire: Profiles of 5 Top Clinical Research Recruitment Agencies
Is There a Place for Integrative Medicine Approaches in Clinical Trials?
How Does Greater Patient Control of Healthcare Data Impact Clinical Trials?
What to Consider When Adopting New Technology in Clinical Trials
eConsent: Definitions & Details
Meet Us at 15th Annual ISMPP Meeting, National Harbor
Meet Anju’s Data Division at Eyeforpharma Philadelphia 2019
Precision Medicine: Its Impact on Clinical Trials and Orphan Drugs
Page navigation
«
‹
Page
9
Page
10
Current Page
11
Page
12
Page
13
›
»
Data Protection
|
Privacy Policy
|
Sitemap
©2023 All rights reserved
To top
